KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Thermo Fisher Scientific (TMO) Accumulated Depreciation & Amortization (2016 - 2025)

Thermo Fisher Scientific's Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $7.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 15.73% year-over-year to $7.8 billion, compared with a TTM value of $7.8 billion through Dec 2025, up 15.73%, and an annual FY2025 reading of $7.8 billion, up 15.73% over the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $7.8 billion at Thermo Fisher Scientific, up from $6.8 billion in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $7.8 billion in Q4 2025, with the low at $4.3 billion in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $6.0 billion, with a median of $6.1 billion recorded in 2023.
  • Year-over-year, Accumulated Depreciation & Amortization grew 21.79% in 2023 and then increased 11.14% in 2024.
  • Tracing TMO's Accumulated Depreciation & Amortization over 5 years: stood at $4.3 billion in 2021, then increased by 17.11% to $5.0 billion in 2022, then grew by 21.79% to $6.1 billion in 2023, then rose by 11.14% to $6.8 billion in 2024, then increased by 15.73% to $7.8 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Accumulated Depreciation & Amortization are $7.8 billion (Q4 2025), $6.8 billion (Q4 2024), and $6.1 billion (Q4 2023).